CTRI/2022/02/040562尚未招募3 期
Evaluating clinical efficacy of Guduchyadi compound in the management of Mild to Moderate COVID-19 cases along with comorbid conditions as stand alone and add on medicine.
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- The proportion of the patients becoming RT – PCR Negative after being positive for covid-19
研究概览
简要总结
In the wake of COVID 19, an infectious disease caused by a newly discovered coronavirus,
entire mankind across the globe is suffering. Till date, no medicine or therapy has demonstrated
promising results in either preventing the disease or improving its prognosis to prevent this
infection.The intervention proposed under the project is a herbal combination based on traditional
knowledge of Ayurveda. The intervention is expected to improve quality of life of COVID
patients treated in addition to disease cure without major side effects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 20.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Newly diagnosed COVID-19 confirmed by RT-PCR.
- •2.Mild to Moderate COVID-19 infection.
- •3.Comorbid conditions (HTN, Diabetes, Metabolic Syndrome) 4.Willingness and ability to comply with trial and follow-up procedures.
- •5.Ability to understand the nature of this trial and give written informed consent.
排除标准
- •1.Patients with severe and critical infection will be excluded.
- •2.Patients with severe COVID-19 infection 3.Patients with respiratory failure who need mechanical ventilation 4.Patients who cannot take drug orally 5.Inability or unwillingness to comply with study and/or follow-up procedures 6.Enrolled in other researches for treatment of COVID-19 infection.
结局指标
主要结局
The proportion of the patients becoming RT – PCR Negative after being positive for covid-19
时间窗: baseline (day 0) and after 7th day (day 8) and after 10 days (day 11)
次要结局
- Improvement in quality of life (SF-36 proforma will be used)(30 days follow up after stopping ayurvedic medication)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
Phase 3 4
Kabasura Kudineer, Shakti drops and Turmeric plus in the management of COVID-19CTRI/2020/07/026371Sriveda Sattva Private Limited Sri Sri Tattva30
尚未招募
Phase 3 4
Validation of Classical Ayurvedic formulations in treatment of COVID-19CTRI/2020/06/026197Ministry of AYUSH GoI60
尚未招募
2 期
Clinical trial of ShatPlus as an immunomodulator in adult Covid 19 positive patientsCTRI/2020/06/025999BVG Life Sciences Ltd60
已完成
不适用
Efficacy and Safety of Guduchi Ghan Vati for Covid-19 Asymptomatic PatientsCovid19Asymptomatic ConditionNCT04480398Aarogyam UK91
招募中
不适用
Safety of convalescent plasma (CVP) drawn from mild symptomatic COVID-19 patients.CTRI/2020/08/027285AIIMS100